Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125206141 | 12520614 | 1 | I | 20160602 | 20160701 | 20160701 | PER | US-BAYER-2016-110163 | BAYER | DIETRICH EA; DAVIS K. NITROFURANTOIN AND RENAL FUNCTION: DOES EVIDENCE SUPPORT THE CREATININE CLEARANCE CUTOFF?. CONSULTANT. 2016;56 (4):XX | 77.00 | YR | E | F | Y | 52.00000 | KG | 20160701 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125206141 | 12520614 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 21473 | MODIFIED-RELEASE FILM-COATED TABLET |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125206141 | 12520614 | Drug intolerance | |
125206141 | 12520614 | Pruritus | |
125206141 | 12520614 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |